Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.3%

109 terminated/withdrawn out of 667 trials

Success Rate

75.4%

-11.1% vs industry average

Late-Stage Pipeline

40 trials in Phase 3/4

Results Transparency

47%

156 of 334 completed trials have results

Key Signals

111 recruiting156 with results56 terminated53 withdrawn

Enrollment Performance

Analytics

N/A

284(55.1%)

Phase 2

116(22.5%)

Phase 1

63(12.2%)

Phase 3

20(3.9%)

Phase 4

20(3.9%)

Early Phase 1

12(2.3%)

515Total

N/A(284)

Phase 2(116)

Phase 1(63)

Phase 3(20)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (667)

Showing 20 of 667 trials

NCT07192055Not ApplicableRecruiting

Self-sampling to Optimize Anal Lesion Outcomes

Role: lead

NCT03030248Phase 2Completed

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Role: lead

NCT04197596Phase 1Recruiting

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Role: collaborator

NCT05144828Phase 4Completed

Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection

Role: lead

NCT07221032Phase 1Not Yet Recruiting

FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma

Role: lead

NCT04896606Phase 1Recruiting

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Role: collaborator

NCT05853601Phase 1Recruiting

Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage

Role: lead

NCT03694262Phase 2Completed

The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

Role: lead

NCT07475104Not ApplicableEnrolling By Invitation

Redesigning Surgical Care for Patients in Wisconsin

Role: collaborator

NCT03707431Not ApplicableCompleted

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Role: collaborator

NCT04721171Not ApplicableTerminated

Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.

Role: lead

NCT07463027Not ApplicableEnrolling By Invitation

Veteran's Interdisciplinary Care for Traumatic Brain Injury and Co-Occurring Disorders Rehabilitation Trial

Role: lead

NCT07507396Not ApplicableNot Yet Recruiting

Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Temperature Management: Evaluation of Temple Touch Pro

Role: lead

NCT02348684Completed

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

Role: lead

NCT02918292Phase 2Completed

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Role: lead

NCT03194971Completed

NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy

Role: lead

NCT03150004Phase 2Terminated

Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Role: lead

NCT04835129Phase 2Active Not Recruiting

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Role: lead

NCT03286530Phase 2Active Not Recruiting

Ruxolitinib + Allogeneic Stem Cell Transplantation in AML

Role: collaborator

NCT04278989Early Phase 1Completed

Inhibition of Oral Tumorigenesis by Antitumor B

Role: lead